{"entity":{"type":"insider","cik":"0001478485","url":"/insider/0001478485","json_url":"/insider/0001478485.json","name":"Hecht Peter M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":11,"first":"2012-11-06","last":"2021-06-07","span_basis":"filed_date"},"name_variants":[{"name":"Hecht Peter M","source":"filing","n_filings":11,"first_seen":"2012-11-06","last_seen":"2021-06-07"}],"transactions":[{"id":5289858,"accession":"0001140361-21-020090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-020090","line_url":"/filing/0001140361-21-020090#line-1","is_derivative":false,"issuer_cik":"0001478485","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478485","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":823170.0,"shares_display":"823,170","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":2699997.6,"total_display":"2,699,997.60","total_whole":"2,699,998","shares_owned_after":2047698.0,"shares_owned_after_display":"2,047,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-07","scope":"insider"},{"id":4594183,"accession":"0001140361-21-016532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-016532","line_url":"/filing/0001140361-21-016532#line-1","is_derivative":false,"issuer_cik":"0001478485","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478485","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":302000.0,"shares_display":"302,000","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":733860.0,"total_display":"733,860.00","total_whole":"733,860","shares_owned_after":1224528.0,"shares_owned_after_display":"1,224,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider"},{"id":4686230,"accession":"0001140361-21-016304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-21-016304","line_url":"/filing/0001140361-21-016304#line-2","is_derivative":false,"issuer_cik":"0001478485","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478485","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":398001.0,"shares_display":"398,001","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":1006942.53,"total_display":"1,006,942.53","total_whole":"1,006,943","shares_owned_after":922528.0,"shares_owned_after_display":"922,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-06","scope":"insider"},{"id":4686222,"accession":"0001140361-21-016304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-016304","line_url":"/filing/0001140361-21-016304#line-1","is_derivative":false,"issuer_cik":"0001478485","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478485","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":687000.0,"total_display":"687,000.00","total_whole":"687,000","shares_owned_after":524527.0,"shares_owned_after_display":"524,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-06","scope":"insider"},{"id":7945040,"accession":"0001209191-19-005422","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-005422","line_url":"/filing/0001209191-19-005422#line-7","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29551.0,"shares_display":"29,551","price_per_share":12.23,"price_display":"12.23","price_state":"stated","total_value":361408.73,"total_display":"361,408.73","total_whole":"361,409","shares_owned_after":4696917.0,"shares_owned_after_display":"4,696,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-25","filed_date":"2019-01-25","scope":"insider"},{"id":7945031,"accession":"0001209191-19-005422","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-005422","line_url":"/filing/0001209191-19-005422#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.7,"price_display":"12.70","price_state":"stated","total_value":381000.0,"total_display":"381,000.00","total_whole":"381,000","shares_owned_after":4696917.0,"shares_owned_after_display":"4,696,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-24","filed_date":"2019-01-25","scope":"insider"},{"id":7945024,"accession":"0001209191-19-005422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-005422","line_url":"/filing/0001209191-19-005422#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.66,"price_display":"12.66","price_state":"stated","total_value":379800.0,"total_display":"379,800.00","total_whole":"379,800","shares_owned_after":4696917.0,"shares_owned_after_display":"4,696,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-23","filed_date":"2019-01-25","scope":"insider"},{"id":4631646,"accession":"0001209191-17-064761","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-064761","line_url":"/filing/0001209191-17-064761#line-5","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57405.0,"shares_display":"57,405","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":861075.0,"total_display":"861,075.00","total_whole":"861,075","shares_owned_after":4696917.0,"shares_owned_after_display":"4,696,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-07","filed_date":"2017-12-08","scope":"insider"},{"id":4631639,"accession":"0001209191-17-064761","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-064761","line_url":"/filing/0001209191-17-064761#line-3","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56000.0,"shares_display":"56,000","price_per_share":15.24,"price_display":"15.24","price_state":"stated","total_value":853440.0,"total_display":"853,440.00","total_whole":"853,440","shares_owned_after":4696917.0,"shares_owned_after_display":"4,696,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-06","filed_date":"2017-12-08","scope":"insider"},{"id":4336569,"accession":"0001209191-17-003679","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-003679","line_url":"/filing/0001209191-17-003679#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32994.0,"shares_display":"32,994","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":511407.0,"total_display":"511,407.00","total_whole":"511,407","shares_owned_after":4670322.0,"shares_owned_after_display":"4,670,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-12","filed_date":"2017-01-13","scope":"insider"},{"id":4336560,"accession":"0001209191-17-003679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-003679","line_url":"/filing/0001209191-17-003679#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32993.0,"shares_display":"32,993","price_per_share":15.84,"price_display":"15.84","price_state":"stated","total_value":522609.12,"total_display":"522,609.12","total_whole":"522,609","shares_owned_after":4670322.0,"shares_owned_after_display":"4,670,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-11","filed_date":"2017-01-13","scope":"insider"},{"id":2697604,"accession":"0001209191-16-107962","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-107962","line_url":"/filing/0001209191-16-107962#line-6","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":10.66,"price_display":"10.66","price_state":"stated","total_value":426400.0,"total_display":"426,400.00","total_whole":"426,400","shares_owned_after":4670322.0,"shares_owned_after_display":"4,670,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-11","filed_date":"2016-03-11","scope":"insider"},{"id":2697582,"accession":"0001209191-16-107962","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-107962","line_url":"/filing/0001209191-16-107962#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":10.63,"price_display":"10.63","price_state":"stated","total_value":425200.0,"total_display":"425,200.00","total_whole":"425,200","shares_owned_after":4670322.0,"shares_owned_after_display":"4,670,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-10","filed_date":"2016-03-11","scope":"insider"},{"id":2697573,"accession":"0001209191-16-107962","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-107962","line_url":"/filing/0001209191-16-107962#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":434800.0,"total_display":"434,800.00","total_whole":"434,800","shares_owned_after":4670322.0,"shares_owned_after_display":"4,670,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-09","filed_date":"2016-03-11","scope":"insider"},{"id":8928991,"accession":"0001209191-15-085446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-085446","line_url":"/filing/0001209191-15-085446#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73418.0,"shares_display":"73,418","price_per_share":11.07,"price_display":"11.07","price_state":"stated","total_value":812737.26,"total_display":"812,737.26","total_whole":"812,737","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-15","scope":"insider"},{"id":8811813,"accession":"0001209191-15-027488","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-027488","line_url":"/filing/0001209191-15-027488","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":15.62523584,"price_display":"15.63","price_state":"stated","total_value":1953154.48,"total_display":"1,953,154.48","total_whole":"1,953,154","shares_owned_after":4141417.0,"shares_owned_after_display":"4,141,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-18","scope":"insider","n_lines":2},{"id":8811810,"accession":"0001209191-15-027488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-027488","line_url":"/filing/0001209191-15-027488#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":15.6,"price_display":"15.60","price_state":"stated","total_value":1170000.0,"total_display":"1,170,000.00","total_whole":"1,170,000","shares_owned_after":4141417.0,"shares_owned_after_display":"4,141,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-18","scope":"insider"},{"id":8669214,"accession":"0001209191-15-021847","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-15-021847","line_url":"/filing/0001209191-15-021847#line-7","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6200.0,"shares_display":"6,200","price_per_share":15.71,"price_display":"15.71","price_state":"stated","total_value":97402.0,"total_display":"97,402.00","total_whole":"97,402","shares_owned_after":4141417.0,"shares_owned_after_display":"4,141,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-03","filed_date":"2015-03-03","scope":"insider"},{"id":8669208,"accession":"0001209191-15-021847","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-021847","line_url":"/filing/0001209191-15-021847#line-5","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13908.0,"shares_display":"13,908","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":222528.0,"total_display":"222,528.00","total_whole":"222,528","shares_owned_after":4141417.0,"shares_owned_after_display":"4,141,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider"},{"id":8669202,"accession":"0001209191-15-021847","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-021847","line_url":"/filing/0001209191-15-021847","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43334.0,"shares_display":"43,334","price_per_share":15.678948631559514,"price_display":"15.68","price_state":"stated","total_value":679431.56,"total_display":"679,431.56","total_whole":"679,432","shares_owned_after":4141417.0,"shares_owned_after_display":"4,141,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-27","filed_date":"2015-03-03","scope":"insider","n_lines":2},{"id":2125634,"accession":"0001209191-12-051911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-051911","line_url":"/filing/0001209191-12-051911#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478485","owner_name":"Hecht Peter M","owner_display_name":"Hecht Peter M","owner_url":"/insider/0001478485","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":11.65,"price_display":"11.65","price_state":"stated","total_value":582500.0,"total_display":"582,500.00","total_whole":"582,500","shares_owned_after":72803.0,"shares_owned_after_display":"72,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-05","filed_date":"2012-11-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001755237","name":"Cyclerion Therapeutics, Inc.","url":"/issuer/0001755237","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2021-05-06","last_seen":"2021-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Director, Officer (Chief Executive Officer)","n_filings":8,"first_seen":"2012-11-06","last_seen":"2019-01-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001478485","retrieved_at":"2026-08-22T11:20:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}